Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON
  1. Startseite
  2. Aktien
  3. Kanada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. InnoCan Pharma Corporation
  6. News
  7. Andere Sprachen
    INNO   CA45783P1027

INNOCAN PHARMA CORPORATION

(A2PSPW)
ÜbersichtKurseChartsNewsUnternehmenFinanzenDerivate 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über INNOCAN PHARMA CORPORATION
06.09.INNOCAN PHARMA : CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release ..
03.09.Innocan Pharma Corporation Conducts Recent Experimental Study of its CBD-Loaded Liposom..
03.09.Innocan Pharma's CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Relea..
03.09.CANNABIS EXECUTIVES PRESENT : Cannabis Investor Conference September 8th & 9th
27.08.Innocan Pharma Received Proceeds of CAD $8.2M from the Exercise of Warrants since Janua..
18.08.Innocan Pharma Corporation Enters into Research and License Agreement with Ramot
18.08.Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the ..
11.08.Innocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in C..
11.08.Innocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in C..
03.08.Innocan Pharma Corporation Updates Its Progress in the Pre-Clinical Studies of Its CBD-..
03.08.Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Lipos..
28.07.Innocan Pharma Announces the Filing of a Patent Application for the Treatment and Preve..
14.07.Iinnocan Pharma Corporation Announces Addition of Izhar Shay to its Advisory Committee
14.07.Former Israeli Minister of Science and Technology and Highly Influential Venture Capita..
12.07.INNOCAN PHARMA : Announces Filing of International Patent Application for Topical Treatmen..
09.07.Innocan Pharma Corporation Announces Filing of International Patent Application for Top..
09.07.Innocan Pharma Announces Filing of International Patent Application for Topical Treatme..
02.07.Innocan Pharma Corporation Signs an Exclusive Distribution Agreement with Health Invest..
01.07.Innocan Pharma and Health Investment Group S.A. Sign Exclusive Distribution Agreement f..
25.06.INNOCAN PHARMA : CBD Integrated Anti-Aging Sleeping Mask Demonstrates a Reduction of the A..
24.06.Innocan Pharma Corporation Cbd Integrated Anti-Aging Sleeping Mask Demonstrates A Reduc..
24.06.Innocan Pharma's CBD Integrated Anti-Aging Sleeping Mask Demonstrates a Reduction of th..
17.06.INNOCAN PHARMA : Clinical Study Validates Innocan Pharma's SHIR CBD Eye Serum as an Anti-P..
16.06.Innocan Pharma Sigs an Agreement with Brandzon Co to Establish A Joint Venture for Mark..
16.06.Innocan Pharma Corporation Completes a Cosmetic Clinical Study of SHIR® CBD Eye Serum o..
16.06.Clinical Study Validates Innocan Pharma's SHIR(R) CBD Eye Serum as an Anti-Puffiness So..
14.06.Innocan Pharma Announces Patent Application for Novel Cannabis-Based Vaginal Moisturize..
14.06.Innocan Pharma Announces Patent Application for Novel Cannabis-Based Vaginal Moisturize..
11.06.Innocan Pharma's Liposome Platform Technology Demonstrates a 7-Week Prolonged Release o..
11.06.Innocan Pharma's Liposome Platform Technology Demonstrates a 7-Week Prolonged Release o..
09.06.Innocan Pharma Among Leading CBD Pharma Companies to Participate at Lytham Partners Sum..
31.05.Innocan Pharma Corporation Reports Earnings Results for the First Quarter Ended March 3..
14.05.Innocan Pharma's CBD Loaded Liposome Platform Technology Receives Positive Results from..
14.05.Innocan Pharma's CBD Loaded Liposome Platform Technology Receives Positive Results from..
10.05.Innocan Pharma Engages Lytham Partners to Lead Investor Relations and Shareholder Commu..
06.05.Innocan Pharma Announces Trading on the OTCQB Venture Market and DTC Eligibility of Its..
22.04.Innocan Pharma and Polyflame Announce an Exclusive Distribution Agreement in France
22.04.Innocan Pharma and Polyflame Announce an Exclusive Distribution Agreement in France
06.04.Innocan Pharma Corporation Appoints Richard Serbin to its Advisory Committee
06.04.Richard Serbin, Former Johnson & Johnson's VP and a Leading Global Strategy Advisor in ..
01.04.Innocan Reports Q4 2020 Financial Results
31.03.Innocan Pharma Corporation Reports Earnings Results for the Full Year Ended December 31..
23.03.InnoCan Pharma Corporation Appoints Mitchell Kline to Its Scientific Advisory Committee
23.03.Leading American Dermatologist Dr. Mitchell Kline to Join Innocan Pharma's Scientific A..
16.03.Innocan Pharma Announces Proceeds of CDN $ 3.1M from the Exercise of Warrants Since Jan..
10.03.Innocan Pharma Announces Patent Application for Novel Cannabis-Based Anti-Itch Treatmen..
10.03.Innocan Pharma Announces Patent Application for Novel Cannabis-Based Anti-Itch Treatmen..
22.02.InnoCan Pharma Corporation Announces the Completion of Its First Full-Scale Manufacturi..
22.02.Innocan Pharma Announces the Completion of its First Full-Scale Manufacturing Run in th..
28.01.Innocan Pharma Announces Proceeds of CDN $ 1.8M from the Exercise of Warrants Since Dec..
22.01.Innocan Pharma Announces Successful Production of CBD Loaded Liposomes Under Aseptic Co..
22.01.Innocan Pharma Announces Successful Production of CBD Loaded Liposomes under Aseptic Co..
14.01.InnoCan Pharma Corporation Announces Successful Completion of a Large-Scale Production ..
14.01.Innocan Pharma Successfully Completes Large Scale Production of Exosomes
05.01.Innocan Pharma Announces the Launch of Its Commercial Website
2020Innocan Pharma Announces Closing of Private Placement
2020InnoCan Pharma Corporation announced that it has received CAD 2.367804 million in fundi..
2020InnoCan Pharma Corporation Announces the Completion of Its First Full-Scale Manufacturi..
2020Innocan Pharma Announces the Successful Completion of Its First Full-Scale Manufacturin..
2020Innocan Pharma Completes Its Trademark Registration in the EU, UK and Switzerland
2020Innocan Pharma to Participate in the Lytham Partners End of Year 1x1 Conference
2020Innocan Reports Q3 2020 Financial Results
2020Innocan Pharma Corporation Reports Earnings Results for the Third Quarter Ended Septemb..
2020Innocan Pharma Corporation Announces the Launch of Two Therapeutic Studies on Small and..
2020Innocan Moves to an Advanced Efficacy Trial on Animals of Its Liposome-CBD Injection, F..
2020Innocan Enters Into Distribution Agreement to Sell its CBD Derma Cosmetic Products in G..
2020Innocan Pharma's Relief & Go CBD Spray Successfully Passes Safety Assessments and Is Ap..
2020Innocan Pharma's Relief & Go CBD Spray Successfully Passes Safety Assessments and is Ap..
2020Innocan Pharma Announces Publication of Two Studies Supporting its CLX Therapy for COVI..
2020Innocan Pharma Announces the Publication of Two Studies Supporting Its CLX Therapy for ..
2020Innocan Pharma's Clinical Study in the US Indicates That More Than 90% of Participants ..
2020Innocan Pharma's Clinical Study in the US Indicates that More than 90% of Participants ..
2020Innocan Pharma's Cosmetic Clinical Study Indicates a 90% Wrinkle Reduction After Using ..
2020Innocan Pharma's Cosmetic Clinical Study Indicates a 90% Wrinkle Reduction After Using ..
2020Innocan Pharma Corporation Provides Clinical Update of its Unique CBD-Loaded Liposome P..
1  2Weiter